Modular Bioscience
About:
Modular Bioscience develops artificial restriction enzymes for the development of diagnostics and synthetic biology tools.
Website: https://modbiosci.com/
Top Investors: Foothill Ventures
Description:
Modular Bioscience develops artificial restriction enzymes for the development of diagnostics and synthetic biology tools. The company's enzymes are used in the diagnosis of genetic diseases, liquid biopsy, and detection of infectious diseases including COVID-19, enabling users to get early treatment.
Total Funding Amount:
$500000
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)modbiosci.com
Founders:
Huimin Zhao, James Zhang
Number of Employees:
Last Funding Date:
2018-04-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai